Infanrix hexa.

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Streptococcal

Phase 3

Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule

CompletedNCT00307034

GlaxoSmithKlineInfections, Streptococcal

Start: 2006-01-01End: 2007-01-25Updated: 2018-06-08

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

CompletedNCT00496015

GlaxoSmithKlineInfections, Streptococcal

Start: 2007-07-02End: 2009-02-17Updated: 2019-01-18

Related Papers

Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol.

2013-02-0536 citations

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

2009-10-01212 citations